Burden and clinical features of chronic obstructive pulmonary disease (COPD). (Q35863966)

10 August 2017

1 reference

title

Burden and clinical features of chronic obstructive pulmonary disease (COPD). (English)

1 reference

chronic obstructive pulmonary disease

10 August 2017

1 reference

Romain A Pauwels

1

1 reference

PubMed ID

15313363

10 August 2017

Klaus F Rabe

series ordinal

2

1 reference

PubMed ID

15313363

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

364

1 reference

10 August 2017

9434

1 reference

10 August 2017

613-620

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Chronic exposure to high levels of particulate air pollution and small airway remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Health status measurement in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Worldwide epidemiology of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

The costs of treating COPD in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Smoking and lung function of Lung Health Study participants after 11 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Health effects of passive smoking. 8. Passive smoking and risk of adult asthma and COPD: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

National burden of disease in India from indoor air pollution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Endotoxin exposure as a major determinant of lung function decline in pig farmers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Distinguishable types of dyspnea in patients with shortness of breath

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

1 reference

7 January 2021

Physician perceptions and management of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Alteration in breathing pattern with progression of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

FORCED EXPIRATORY TIME: A SIMPLE TEST FOR AIRWAYS OBSTRUCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Ongoing airway inflammation in patients with COPD who do not currently smoke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Do GOLD stages of COPD severity really correspond to differences in health status?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

The natural history of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916855-4

7 January 2021

10.1016/S0140-6736(04)16855-4

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15313363